Loading
Preparing the next Annolyse view.
Company archive
Each company archive keeps the publication history in release order, with the newest Annolyse briefing first.
Archive navigation
Company and sector routes have dedicated HTML, while the archive stays ordered by publication date.
Showing 1-7 of 7 published briefings.
Headline NPAT rose 27.2% flattered by a lower minority share, while capex nearly tripled and pre-lease free cash flow dropped to $15.6m from $23.1m.
Published 22 April 2026
Read briefingStrong H2 skew and a small net cash position lift the earnings read, but pharmacy same-store retail fell 9% and cash conversion versus NPAT softened.
Published 22 April 2026
Read briefingEBIT grew 7.8% and net debt more than halved, but bottom-line growth was near-zero and segment mix is doing the heavy lifting.
Published 22 April 2026
Read briefingContinuing earnings softened on retail pressure while a $34.8m cash drawdown and rising borrowings shifted the balance-sheet direction.
Published 22 April 2026
Read briefingHeadline 29.5% revenue drop is largely a segment-exit optical, but Pharmacy and Medical margins compressed and net cash of $18.9m flipped to net...
Published 22 April 2026
Read briefingHeadline profit is flattered by the Community Health discontinued-operation gain, while continuing-operation earnings and cash conversion both...
Published 21 April 2026
Read briefingCommunity Health and Medical drove the earnings step-up while a higher effective tax rate trimmed NPAT growth below PBT growth.
Published 21 April 2026
Read briefingEmail updates
Get full analytical briefings by email as new coverage is published.